Trial Profile
A RANDOMIZED, SINGLE CENTER, DOUBLE BLIND, TWO-PERIOD, CROSSOVER GLUCOSE CLAMP STUDY TO TEST BIOEQUIVALENCE BETWEEN TWO FORMULATIONS OF RECOMBINANT HUMAN INSULINS; WOSULIN R (200 IU) WITH WOSULIN R (100 IU) IN HEALTHY SUBJECTS. - W-WOS(R)-103
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 04 Jul 2019
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Wockhardt
- 17 Jun 2019 Status changed from recruiting to active, no longer recruiting.
- 01 Sep 2016 New trial record
- 26 Jul 2016 Status changed from not yet recruiting to recruiting.